Symbol: |
SPG21
|
Description: |
spastic paraplegia 21 (autosomal recessive, Mast syndrome) [Source:HGNC Symbol;Acc:20373]
|
Location: |
Chr15:65255362-65282648[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:191
Gene |
Compound |
Gen_sig |
Exp_pattern |
SPG21 |
6H-Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- |
0.044 |
Up |
SPG21 |
NSC 105348 |
0.044 |
Up |
SPG21 |
Thiothixene |
0.014 |
Down |
SPG21 |
Lobinaline, monohydrochloride |
0.004 |
Down |
SPG21 |
NSC 112789 |
0.044 |
Down |
SPG21 |
NSC 116532 |
0.004 |
Down |
SPG21 |
NSC 11850 |
0.011 |
Down |
SPG21 |
Guanidine, 1-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-3-[4-[[2-(diisopropylamino)ethyl]amino]-6-methyl-2-pyrimidinyl]- |
0.03 |
Down |
SPG21 |
NSC 128166 |
0.004 |
Down |
SPG21 |
NSC 13477 |
0.001 |
Down |
SPG21 |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.003 |
Down |
SPG21 |
Benzamide, N-[2-(diethylamino)ethyl]-4-methyl-2-nitro- 3-(phenylmethoxy)- |
0.011 |
Down |
SPG21 |
NSC 15795 |
0.007 |
Down |
SPG21 |
NSC 16857 |
0.013 |
Down |
SPG21 |
Pimozide |
0.023 |
Down |
Expression pattern: Sensitivity / Resistance
Total:13 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:11
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:63
Total:5 Current:1
[First] [Prev]  Next Last 
|